Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer
The results of a UCLA study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatm
Source: newswise.com